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Carcinogenic agents can influence the carcinogenic process either by mutating critical target genes or by increasing the number of cells at risk for
mutations. Cytogenetic and molecular studies of asbestos-related cancers indicate that inactivation or loss of multiple tumor suppressor genes
occurs during lung cancer development. Aneuploidy and other chromosomal changes induced by asbestos fibers may be involved in genetic alter-
ations in asbestos-related cancers. Furthermore, asbestos fibers may influence the carcinogenic process by inducing cell proliferation, free radicals,
or other promotional mechanisms. Therefore, asbestos fibers may act at multiple stages of the carcinogenic process by both genetic and epigenetic
mechanisms. Biopersistence is undoubtedly important in fiber carcinogenicity. However, the time required for a fiber to remain in the lung to exert a
cancer-related effect is difficult to specify. - Environ Health Perspect 102(Suppl 5):19-23 (1994)
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To understand the importance ofbiopersis-
tence in fiber carcinogenesis, it is necessary
to elucidate how and when fibers influence
the carcinogenic process. Cancer is a
chronic disease requiring a latency period
of several decades. The necessity of this
latency can be explained in large part by
the multistep nature of the neoplastic
process (1-3). There is now overwhelming
evidence to support the concept that most,
if not all, cancers develop as the conse-
quence of mutations in critical genes
(1-3). The number of mutations required
for a given cancer is not known precisely
and can be variable; however, many cancers
have mutations in multiple genes; often 5
to 20 mutations in cancer-related genes are
found in human tumors (1-3).
The critical target genes for cancers can
be divided into two distinct classes-pro-
tooncogenes and tumor suppressor genes.
Protooncogenes are activated by point
mutations, chromosomal translocations,
and gene amplification (1-3). Once acti-
vated or inappropriately expressed, these
genes act as positive regulators of cell
growth and invasion. Tumor suppressor
genes, in contrast, are negative regulators of
cancer cells. These genes must be inacti-
vated, lost, or mutated for malignant prop-
erties of cancer cells to manifest (1-3).
Mutational mechanisms for tumor suppres-
sor genes in cancers include chromosome
losses, gene deletions, and point mutations
(1-3). Recent evidence strongly indicates
that different steps in the multistep process
ofcarcinogenesis are defined by mutational
alterations of tumor suppressor genes (2).
Common adult tumors in humans fre-
quently have mutations in two to four dif-
ferent tumor suppressor genes, indicating
multiple negative controls of malignant
cells (1-3).
The most likely mechanism for acquisi-
tion ofmultiple mutations in the same cell
is by clonal evolution (4). According to
this model (Figure 1), cells with one criti-
cal mutation clonally expand. By increasing
the number ofcells with the first mutation,
the probability ofa second mutation in the
same cells increases. Once a cell with two
mutations arises, it will also clonally
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expand and thereby increase the probability
ofa third mutation within one ofits prog-
eny. This cell can then undergo further
mutations by clonal evolution, allowing
malignant development.
Carcinogenic agents can accelerate this
process by several mechanisms at different
stages. Neoplastic development can be
enhanced by agents that mutate critical tar-
get genes, i.e., by either inactivation of
tumor suppressor genes or activation of
protooncogenes. Furthermore, agents that
influence the rate of clonal expansion of
cells will increase the number ofcells at risk
for mutations and thereby increase the rate
of neoplastic progression and shorten the
latency period for cancer development.
In the context of the multistep/multi-
gene model of cancer, at what stages or
steps do asbestos and other mineral fibers
act, and what are the implications of these
mechanisms for the role of biopersistence
in carcinogenic potential of fibers?
Examination ofthe molecular alterations in
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Figure 1. Inthis model ofneoplastic development it is assumedthatthe heritablealterations ofdifferentgenes occuras
theconsequence ofchemically induced orspontaneous events.
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asbestos-related cancers (e.g., mesothe-
liomas) provides insight into the critical
events in these neoplasms.
Cytogenetic analyses often provide the
first clues as to the critical changes for a
given tumor type. Nonrandom chromo-
some changes indicate chromosomal
regions where critical target genes for can-
cers reside. Specific nonrandom chromo-
some alterations have been observed in
human mesotheliomas (5). Of particular
interest are alterations involving human
chromosomes 1, 3, 5, 6, and 7 (Table 1).
Deletions or rearrangements involving
chromosome 1 have been reported in sev-
eral studies involving human mesothelial
cells (5-14); Gibaz et al. report that these
aberrations occur with a frequency of
>60% (8). A gene important for cellular
senescence is located on human chromo-
some 1 (15). Alterations ofthis gene play a
role in cellular immortalization and thus
may be critical for development or progres-
sion of the neoplastic phenotype.
Aberrations involving chromosome 1
frequently are observed in many other
types of human cancer, including tumors
of the reproductive organs, leukemias,
breast cancer, colon carcinoma, melanoma,
multiple endocrine neoplasia, and neurob-
lastoma (15).
A second commonly observed cytoge-
netic alteration in human mesothelioma cells
is deletion or monosomy of chromosome 3
(7,9,10,16). A tumor suppressor gene
involved in several human cancers, including
lung cancer (17), renal cell carcinoma (17),
and cervical carcinoma (18), is thought to
be located on chromosome 3p. Alterations in
this region of chromosome 3 observed in
mesotheliomas suggest that this same tumor
suppressor gene could be involved in
mesothelioma development. Losses oftumor
suppressor gene functions occur in several
types of human cancer (1-3), but a direct
role for this or any other tumor suppressor
gene in the genesis of mesothelioma has yet
to be demonstrated.
Extra copies (gains or polysomes) of
chromosome 7 (6,11) have been observed
frequently in human mesotheliomas sug-
gesting that increased dosage of a gene on
chromosome 7 may play a role in transfor-
mation ofmesothelial cells. Chromosome 7
is the site of the protooncogene HER-1,
which encodes the epidermal growth factor
receptor (EGF-R) (19). Trisomy or
polysomy of chromosome 7 has been
observed in other types of human cancer
(20), and it has been speculated that this
could be responsible for altered expression
of the EGF-R in melanoma cells (20). To
date, the role of EGF-R expression in the
development ofmesothelioma has not been
thoroughly investigated. In addition,
platelet-derived growth factor-alpha
(PDGF-ox) also is located on human chro-
mosome 7 (21), and a role for this growth
factor in the development ofmesothelioma
has been suggested (5).
In a recent report, Pelin-Enlund and
coworkers reported an excess of the short
arm ofchromosome 5 in 6 out of7 human
mesothelioma cell lines (14). In addition,
that report cited monosomy of chromo-
some 13, the chromosome known to con-
tain the human retinoblastoma (Rb) tumor
suppressor gene (3). Loss of normal Rb
gene function has been observed in human
lung tumors (3), but no direct evidence
exists for a role for this gene in mesothe-
lioma development.
Deletion or loss of chromosome 6
recently was reported as the sole karyotypic
abnormality in a mesothelioma (22),
which suggests that loss of a gene on the
long arm of this chromosome may be pri-
mary in mesotheliomas.
Losses of whole chromosomes or dele-
tions of portions of specific chromosomes
provide evidence for the loss oftumor sup-
pressor genes in mesotheliomas, which is
an important step in the genesis of most
human tumors (1-3). Extra copies of
specific chromosomes are also commonly
observed in mesotheliomas; this finding
suggests a possible dosage effect, such as
amplification and overexpression of pro-
tooncogenes. Both normal and trans-
formed mesothelial cells express and
respond to a variety of growth factors and
growth factor receptors (5), which can act
as oncogenes if overexpressed or inappro-
priately expressed. However, a specific
oncogene involved in mesotheliomas has
not yet been identified (5).
Although asbestos and other mineral
fibers do not induce gene mutations, they
are active as chromosomal mutagens
(5,23,24). Chromosomal gains and losses
and chromosomal deletions are induced
Table 1. Frequentanonrandom cytogenetic alterations associated with transformation of human mesothelial cells.
Chromosome Monosomy ordeletion Reference polysomy Rearrangement ofstructural abnormalities
1 Flejter etal. (7), Gibas etal. (8), Tiainen etal. (11), Mark(12),Versnel etal.
Popescu etal. (9), Bello etal. (10) (13), Pelin-Enlund etal. (14), Olofsson and Mark(6)
2 Olofsson and Mark(6) Gibas etal. (8)
3 Flejteretal. (7), Bello etal. (10), Gibas etal. (8), Mark(12), Decker etal. (33)
Popescu etal. (9), Stenman etal. (16)
4 Versnel etal.(13), Olofsson and Mark(6)
5 Bello etal. (10), Klominek etal. (30) Pelin-Eniund etal. (14) Versnel etal. (13), Ke etal. (32)
6 Bello etal.(10), Gibas etal.(8), Versnel etal. (13), Ke etal.(32)
Stenman etal. (16), Meloni etal. (22)
7 Popescu etal. (9) Tiainen etal.(11), Olofsson and Mark(6) Ke etal. (32)
9 Klominek etal. (30), Pelin-Enlund etal. (14) Gibas etal. (8),Versnel etal. (13)
11 Lechneretal. (31) Tiainen etal. (11) Gibas etal. (8), Versnel etal. (13)
12 Versnel etal. (13), Decker etal. (33)
13 Pelin-Enlund etal. (14), Mark(12) Versnel etal. (13), Ke etal. (32)
17 Olofsson and Mark(6) Versnel etal. (13), Gibas etal. (8)
18 Flejteretal. (7), Olofsson and Mark(6)
21 Olofsson and Mark(6), Lechner etal. (31)
22 Flejter etal.(7), Tiainen etal.(11), Versnel etal. (13),
Gibas etal. (8), Mark(12), Stenman etal.(16),
Olofsson and Mark(6) Versnel etal.(13)
aReported in two or more studies.
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following exposure of human and rodent
cells, including mesothelial cells, to
asbestos fibers.
A mechanism for asbestos-induced ane-
uploidy, i.e., losses and gains of individual
chromosomes, has been proposed (25,26).
In the first step, crocidolite asbestos fibers
are taken up by the cells by phagocytosis
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within 24 hr after treatment (25,26); the
intracellular fibers accumulate around the
perinuclear region of the cells 24 to 48 hr
after exposure. When the cells undergo
mitosis, the physical presence of the fibers
results in interference with chromosome
segregation. Analysis of chrysotile-exposed
cells in anaphase (25) reveals a large
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Figure 2 The multistep process of carcinogenesis results from multiple genetic changes required for a normal cell to
evolve into a malignant cell. Asbestos fibers may initiate this process by a chromosomal mutation. However, additional
mutations are required for clinically evident neoplasms. These secondary mutations are more likely to arise if the initi-
ated (mutant-i) cells are stimulated to proliferate, forexample, byfiber-related promotional mechanisms. Tumor promo-
tion results in clonal expansion of the initiated cells, but preneoplastic cells must progress and acquire additional
mutations. Asbestos fibers may influence this progression either byinducing chromosomal mutations inthe intermediate
cells or by stimulating cellular proliferation. Asbestos fibers also may stimulate proliferation ofthe normal cells thereby
increasing the rate of either asbestos-induced or spontaneous mutations. Therefore, asbestos fibers can influence the
carcinogenic process either at early or late stages by both genetic and epigenetic mechanisms. Synergism with other
agents (e.g., cigarette smoke) can be explained byasbestosacting at one step and the synergistic carcinogen acting ata
different step inthismultistep process.
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Figure 3. Pathways ofasbestos carcinogenicity. Asbestos fibers may exerttheircarcinogenic effects on mesothelial and
bronchial epithelial cells bydirectand indirect mechanisms. Direct effects can occurfollowingthe physical interaction of
fibers with target cells or by the generation of free radicals from the fiber source. Indirect effects arise following the
interaction of fibers with inflammatory cells that produce mediators such as cytokines and various reactive oxygen
species. As a result, target cells sustain genetic alterations that lead tothe development oftumors. [Taken fromWalker
etal.(5)with permission.]
increase in the number ofcells with abnor-
malities including lagging chromosomes,
bridges, and sticky chromosomes. Asbestos
fibers are observed in the mitotic cells and
appear, in some cases, to interact directly
with the chromosomes. Using ultrastruc-
tural analysis, Wang et al. (27) observed
asbestos fibers apparently interacting with
metaphase chromosomes after treatment of
rat mesothelial cells in culture. It also has
been proposed that the physical interaction
of the asbestos fibers with the chromo-
somes or structural proteins of the spindle
apparatus can cause mis-segregation of
chromosomes during mitosis, resulting in
aneuploidy (25,26). These findings pro-
vide a mechanism, at the chromosomal
level, by which asbestos and other mineral
fibers can induce cell transformation and
cancer.
Asbestos can heritably transform cells
in culture leading to neoplastic transforma-
tion (5,28). Furthermore, asbestos-induced
cell transformation is dependent on fiber
size as is asbestos carcinogenicity, in vivo
(28). Long, thin fibers are more active
than short, thick fibers. Chromosomal
mutation induced by fibers is also fiber-
size dependent, and this is the likely
mechanism for asbestos-induced cell trans-
formation (29).
Since asbestos fibers induce chromoso-
mal mutations, including chromosome
losses and deletions, and since nonrandom
chromosomal losses and deletions are
observed in asbestos-induced cancers, it is
reasonable to assume these events are inter-
related. Losses of tumor suppressor genes
occur at different stages of the multistep
process of carcinogenesis; thus, asbestos-
induced deletions ofthese genes may occur
early or late in the carcinogenic process.
In addition to mutational mechanisms
involving chromosomal alterations,
asbestos fibers may act on the carcinogenic
process by stimulating cell proliferation
(Figure 2). Asbestos fibers may stimulate
proliferation ofnormal cells either by com-
pensatory growth after cytotoxic injury or
by stimulation ofmacrophages and inflam-
matory cells that release cytokines and
growth factors (Figure 3) (5). Cell division
is required for asbestos-induced chromo-
some mutations to occur. Increasing the
rate of cell proliferation may also increase
the number of cells with spontaneous
mutations. Furthermore, asbestos- and
fiber-induced cell proliferation could accel-
erate clonal expansion of initiated or pre-
neoplastic cells, which would promote
neoplastic development. Therefore, asbes-
tos fibers could influence the carcinogenic
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process at either early or late stages by both
genetic and epigenetic mechanisms.
Biopersistence of fibers is undoubtedly
important in their carcinogenic potency.
However, the time required for a fiber to
remain in the lung to exert a cancer-related
effect is difficult to specify. Increasing bio-
logically active exposures to critical target
cells will increase the carcinogenic potency
ofa fiber. Biologically active exposures are
determined by retention and clearance
mechanisms, by durability of the fiber, by
availability of the fibers for interaction
with target cells, and by their reactivity.
Fiber-target cell interactions are deter-
mined both by intrinsic properties offibers
and extrinsic chemical modifications of
fibers in the tissue milieu. Biological mask-
ing offibers by proteins and other biomol-
ecules in vivo can inactivate even persistent
fibers. The critical target cells for fiber car-
cinogenicity include the progenitor cells for
the asbestos-related cancers, e.g., mesothe-
lial and bronchial epithelial cells, as well as
inflammatory cells that release cytokines
and other modifiers of mesothelial and
epithelial cells following fiber stimulation.
Given the multistep nature of the car-
cinogenic process and the multiple mecha-
nisms by which fibers might influence it
(5), it is very difficult to determine the
degree ofbiopersistence necessary for fiber
carcinogenicity. Longer exposures will
increase the probability of a carcinogenic
response, but very short exposures still may
be significant. The mere presence offibers
in the lung, however, does not indicate
biologically active exposures. Fibers in the
lung at the time of disease detection may
not be biologically active, and exposures to
fibers that have not persisted to the point
of disease manifestation may have been
critical for early, preclinical stages.
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